Literature DB >> 25279981

Ascertainment bias causes false signal of anticipation in genetic prion disease.

Eric Vallabh Minikel1, Inga Zerr2, Steven J Collins3, Claudia Ponto4, Alison Boyd3, Genevieve Klug3, André Karch4, Joanna Kenny5, John Collinge5, Leonel T Takada6, Sven Forner6, Jamie C Fong6, Simon Mead5, Michael D Geschwind6.   

Abstract

Anticipation is the phenomenon whereby age of onset in genetic disease decreases in successive generations. Three independent reports have claimed anticipation in Creutzfeldt-Jakob disease (CJD) caused by the c.598G > A mutation in PRNP encoding a p.Glu200Lys (E200K) substitution in the prion protein. If confirmed, this finding would carry clear implications for genetic counseling. We analyzed pedigrees with this mutation from four prion centers worldwide (n = 217 individuals with the mutation) to analyze age of onset and death in affected and censored individuals. We show through simulation that selective ascertainment of individuals whose onset falls within the historical window since the mutation's 1989 discovery is sufficient to create robust false signals both of anticipation and of heritability of age of onset. In our data set, the number of years of anticipation observed depends upon how strictly the data are limited by the ascertainment window. Among individuals whose disease was directly observed at a study center, a 28-year difference between parent and child age of onset is observed (p = 0.002), but including individuals ascertained retrospectively through family history reduces this figure to 7 years (p = 0.005). Applying survival analysis to the most thoroughly ascertained subset of data eliminates the signal of anticipation. Moreover, even non-CJD deaths exhibit 16 years anticipation (p = 0.002), indicating that ascertainment bias can entirely explain observed anticipation. We suggest that reports of anticipation in genetic prion disease are driven entirely by ascertainment bias. Guidelines for future studies claiming statistical evidence for anticipation are suggested.
Copyright © 2014 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25279981      PMCID: PMC4185115          DOI: 10.1016/j.ajhg.2014.09.003

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  53 in total

1.  Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt-Jakob disease in Sephardic Jews of Libyan and non-Libyan origin.

Authors:  L G Goldfarb; A D Korczyn; P Brown; J Chapman; D C Gajdusek
Journal:  Lancet       Date:  1990-09-08       Impact factor: 79.321

Review 2.  Repeat expansion disease: progress and puzzles in disease pathogenesis.

Authors:  Albert R La Spada; J Paul Taylor
Journal:  Nat Rev Genet       Date:  2010-04       Impact factor: 53.242

3.  Differential diagnosis of Jakob-Creutzfeldt disease.

Authors:  Ross W Paterson; Charles C Torres-Chae; Amy L Kuo; Tim Ando; Elizabeth A Nguyen; Katherine Wong; Stephen J DeArmond; Aissa Haman; Paul Garcia; David Y Johnson; Bruce L Miller; Michael D Geschwind
Journal:  Arch Neurol       Date:  2012-12

4.  Testing for age-at-onset anticipation with affected parent-child pairs.

Authors:  D Rabinowitz; Q Yang
Journal:  Biometrics       Date:  1999-09       Impact factor: 2.571

5.  Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease.

Authors:  K Hsiao; Z Meiner; E Kahana; C Cass; I Kahana; D Avrahami; G Scarlato; O Abramsky; S B Prusiner; R Gabizon
Journal:  N Engl J Med       Date:  1991-04-18       Impact factor: 91.245

6.  Ten years of presymptomatic testing for Huntington's disease: the experience of the UK Huntington's Disease Prediction Consortium.

Authors:  P S Harper; C Lim; D Craufurd
Journal:  J Med Genet       Date:  2000-08       Impact factor: 6.318

7.  New simple tests for age-at-onset anticipation: application to panic disorder.

Authors:  W Y Tsai; Gary A Heiman; Susan E Hodge
Journal:  Genet Epidemiol       Date:  2005-04       Impact factor: 2.135

8.  Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study.

Authors:  S Collins; M G Law; A Fletcher; A Boyd; J Kaldor; C L Masters
Journal:  Lancet       Date:  1999-02-27       Impact factor: 79.321

Review 9.  Rapidly progressive dementia.

Authors:  Michael D Geschwind; Aissa Haman; Bruce L Miller
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

10.  Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

Authors:  Randall J Bateman; Chengjie Xiong; Tammie L S Benzinger; Anne M Fagan; Alison Goate; Nick C Fox; Daniel S Marcus; Nigel J Cairns; Xianyun Xie; Tyler M Blazey; David M Holtzman; Anna Santacruz; Virginia Buckles; Angela Oliver; Krista Moulder; Paul S Aisen; Bernardino Ghetti; William E Klunk; Eric McDade; Ralph N Martins; Colin L Masters; Richard Mayeux; John M Ringman; Martin N Rossor; Peter R Schofield; Reisa A Sperling; Stephen Salloway; John C Morris
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

View more
  13 in total

Review 1.  Genetic PrP Prion Diseases.

Authors:  Mee-Ohk Kim; Leonel T Takada; Katherine Wong; Sven A Forner; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

2.  Epilepsy in families: Age at onset is a familial trait, independent of syndrome.

Authors:  Colin A Ellis; Leonid Churilov; Michael P Epstein; Sharon X Xie; Susannah T Bellows; Ruth Ottman; Samuel F Berkovic
Journal:  Ann Neurol       Date:  2019-05-20       Impact factor: 10.422

Review 3.  Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature.

Authors:  Leonel T Takada; Mee-Ohk Kim; Ross W Cleveland; Katherine Wong; Sven A Forner; Ignacio Illán Gala; Jamie C Fong; Michael D Geschwind
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

4.  Quantifying prion disease penetrance using large population control cohorts.

Authors:  Eric Vallabh Minikel; Sonia M Vallabh; Monkol Lek; Karol Estrada; Kaitlin E Samocha; J Fah Sathirapongsasuti; Cory Y McLean; Joyce Y Tung; Linda P C Yu; Pierluigi Gambetti; Janis Blevins; Shulin Zhang; Yvonne Cohen; Wei Chen; Masahito Yamada; Tsuyoshi Hamaguchi; Nobuo Sanjo; Hidehiro Mizusawa; Yosikazu Nakamura; Tetsuyuki Kitamoto; Steven J Collins; Alison Boyd; Robert G Will; Richard Knight; Claudia Ponto; Inga Zerr; Theo F J Kraus; Sabina Eigenbrod; Armin Giese; Miguel Calero; Jesús de Pedro-Cuesta; Stéphane Haïk; Jean-Louis Laplanche; Elodie Bouaziz-Amar; Jean-Philippe Brandel; Sabina Capellari; Piero Parchi; Anna Poleggi; Anna Ladogana; Anne H O'Donnell-Luria; Konrad J Karczewski; Jamie L Marshall; Michael Boehnke; Markku Laakso; Karen L Mohlke; Anna Kähler; Kimberly Chambert; Steven McCarroll; Patrick F Sullivan; Christina M Hultman; Shaun M Purcell; Pamela Sklar; Sven J van der Lee; Annemieke Rozemuller; Casper Jansen; Albert Hofman; Robert Kraaij; Jeroen G J van Rooij; M Arfan Ikram; André G Uitterlinden; Cornelia M van Duijn; Mark J Daly; Daniel G MacArthur
Journal:  Sci Transl Med       Date:  2016-01-20       Impact factor: 17.956

5.  Genetic Prion Disease Caused by PRNP Q160X Mutation Presenting with an Orbitofrontal Syndrome, Cyclic Diarrhea, and Peripheral Neuropathy.

Authors:  Jamie C Fong; Julio C Rojas; Jee Bang; Andrea Legati; Katherine P Rankin; Sven Forner; Zachary A Miller; Anna M Karydas; Giovanni Coppola; Carrie K Grouse; Jeffrey Ralph; Bruce L Miller; Michael D Geschwind
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

6.  Age at onset in genetic prion disease and the design of preventive clinical trials.

Authors:  Eric Vallabh Minikel; Sonia M Vallabh; Margaret C Orseth; Jean-Philippe Brandel; Stéphane Haïk; Jean-Louis Laplanche; Inga Zerr; Piero Parchi; Sabina Capellari; Jiri Safar; Janna Kenny; Jamie C Fong; Leonel T Takada; Claudia Ponto; Peter Hermann; Tobias Knipper; Christiane Stehmann; Tetsuyuki Kitamoto; Ryusuke Ae; Tsuyoshi Hamaguchi; Nobuo Sanjo; Tadashi Tsukamoto; Hidehiro Mizusawa; Steven J Collins; Roberto Chiesa; Ignazio Roiter; Jesús de Pedro-Cuesta; Miguel Calero; Michael D Geschwind; Masahito Yamada; Yosikazu Nakamura; Simon Mead
Journal:  Neurology       Date:  2019-06-06       Impact factor: 9.910

7.  Data-driven phenotype discovery of FMR1 premutation carriers in a population-based sample.

Authors:  Arezoo Movaghar; David Page; Murray Brilliant; Mei Wang Baker; Jan Greenberg; Jinkuk Hong; Leann Smith DaWalt; Krishanu Saha; Finn Kuusisto; Ron Stewart; Elizabeth Berry-Kravis; Marsha R Mailick
Journal:  Sci Adv       Date:  2019-08-21       Impact factor: 14.136

8.  Estimating the Posttest Probability of Long QT Syndrome Diagnosis for Rare KCNH2 Variants.

Authors:  Krystian Kozek; Yuko Wada; Luca Sala; Isabelle Denjoy; Christian Egly; Matthew J O'Neill; Takeshi Aiba; Wataru Shimizu; Naomasa Makita; Taisuke Ishikawa; Lia Crotti; Carla Spazzolini; Maria-Christina Kotta; Federica Dagradi; Silvia Castelletti; Matteo Pedrazzini; Massimiliano Gnecchi; Antoine Leenhardt; Joe-Elie Salem; Seiko Ohno; Yi Zuo; Andrew M Glazer; Jonathan D Mosley; Dan M Roden; Bjorn C Knollmann; Jeffrey D Blume; Fabrice Extramiana; Peter J Schwartz; Minoru Horie; Brett M Kroncke
Journal:  Circ Genom Precis Med       Date:  2021-07-26

9.  The Medical Genome Reference Bank: a whole-genome data resource of 4000 healthy elderly individuals. Rationale and cohort design.

Authors:  Paul Lacaze; Mark Pinese; Warren Kaplan; Andrew Stone; Marie-Jo Brion; Robyn L Woods; Martin McNamara; John J McNeil; Marcel E Dinger; David M Thomas
Journal:  Eur J Hum Genet       Date:  2018-10-24       Impact factor: 4.246

10.  Simulating pedigrees ascertained for multiple disease-affected relatives.

Authors:  Christina Nieuwoudt; Samantha J Jones; Angela Brooks-Wilson; Jinko Graham
Journal:  Source Code Biol Med       Date:  2018-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.